Renascience Inc.

4889・Growth Market・Pharmaceuticals

Official website

Renascience Inc.

4889・Growth Market・Pharmaceuticals

Official website

Renascience Inc.4889

Reference Indicators

Market Cap

214¥100M

P/E (Forecast)

—

P/B

6.5x

Dividend Yield (Forecast)

0.00%

ROE

-9.1%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	139	100	194	132	68
Gross Profit	80	100	165	128	64
Operating Income	-210	-333	-252	-178	-356
Non-operating Income	0	0	0	1	67
Non-operating Expenses	30	—	—	1	10
Ordinary Income	-241	-333	-251	-178	-300
Extraordinary Income	—	—	—	323	—
Extraordinary Losses	11	—	4	1	—
Pre-tax Income	-253	-333	-256	143	-300
Income Taxes	1	1	1	30	1
Net Income	-254	-335	-258	113	-301
EBITDA	-207	-332	-250	-178	—
Gross Margin	58.1%	99.8%	85.3%	97.2%	93.7%
Operating Margin	-151.3%	-332.1%	-130.0%	-134.8%	-520.6%
ROA	-10.4%	-14.8%	-12.4%	6.1%	-8.6%
ROE	-11.6%	-18.0%	-16.1%	6.8%	-9.1%